Despite 330 products in pipeline, stem cell therapies still face commercial challenges – ETHealthWorld.com
|
Despite 330 products in pipeline, stem cell therapies still face commercial challenges
ETHealthWorld.com While steady progress in clinical research and increasing evidence of product effectiveness are significant driving factors for growth in the stem cell therapies market, a number of obstacles remain before they become widely commercially viable … Stem Cell Therapies Still Facing Commercial Challenges |
